[Leukergy in multiple sclerosis before and after treatment with sodium salicylate and dexamethasone (preliminary report)].
The authors determined the leukergic reaction in the blood of multiple sclerosis patients treated with dexamethasone and sodium salicylate. The investigations were done in two groups of 25 patients each. Dexamethasone was used in a daily dose of 4 mg, and sodium salicylate in a dose of 2.0 g. A significant effect of dexamethasone on reduction of the leukergic forms of leucocyte in the peripheral blood of these patients was observed. There was no significant effect of sodium salicylate on leukergy.
D000293:Adolescent; D000328:Adult; D002448:Cell Adhesion / Q000187:drug effects; D003907:Dexamethasone / Q000494:pharmacology / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007962:Leukocytes / Q000187:drug effects / Q000502:physiology*; D008297:Male; D008875:Middle Aged; D009103:Multiple Sclerosis / Q000097:blood* / Q000188:drug therapy; D012980:Sodium Salicylate / Q000494:pharmacology / Q000627:therapeutic use*
D003907:Dexamethasone; D012980:Sodium Salicylate
Leukergia u chorych na stwardnienie rozsiane przed i po leczeniu salicylanem sodu oraz deksametazonem. (Doniesienie wstepne).